in the News

Study: There Is No Country Where Heritable Human Genome Editing Is Permitted

By Farah Qaiser, Forbes [cites CGS' Marcy Darnovsky] | 10.31.2020

In a new study, four researchers reviewed policy documents from 106 countries to map out the policy landscape regarding...

Genomics

Crispr Gene Editing Can Lead to Big Mistakes in Human Embryos

By Amy Dockser Marcus, Wall Street Journal [cites CGS' Marcy Darnovsky] | 10.29.2020

Scientists using the Crispr gene-editing technology in human embryos to try to repair a gene that causes hereditary blindness found it...

Human Genetic Modification

Gene Editing Cannot Be Separated From The Violent History of Eugenics and Medical Racism

By Jude Casimir, Wear Your Voice [cites CGS' Marcy Darnovsky] | 10.27.2020

Henrietta Lacks visited John Hopkins Hospital in 1951, complaining of vaginal bleeding. A mother of five children, Lacks was diagnosed by gynecologist...

Policies

Californians Asked to Pony Up for Stem Cell Research — Again

By Rachel Bluth, California Healthline [cites CGS' Marcy Darnovsky] | 10.21.2020

SACRAMENTO — In an election year dominated by a chaotic presidential race and splashy statewide ballot initiative campaigns, Californians are...

Policies

Election Guide: Here's What You Need to Know About Proposition 14

By Terry McSweeney, NBC Bay Area [cites CGS' Marcy Darnovsky] | 10.04.2020

Proposition 14 on the November ballot asks voters to approve $5.5 billion to continue funding stem cell research in California...

Policies

California Stem Cell Measure Scrutinized in Virus Budget Crunch

By Joyce E. Cutler and Tiffany Stecker, Bloomberg Government | 09.17.2020

California voters will be asked this November to spend big on stem cell research, an expensive proposition that could help...

Policies